Literature DB >> 8306829

Follow-up after screening for colorectal neoplasms with fecal occult blood testing in a controlled trial.

J Kewenter1, H Brevinge, B Engarås, E Haglind, C Ahrén.   

Abstract

PURPOSE: The aim of this study was to investigate the number of new colorectal neoplasms during the first seven years after the end of rescreening in a prospective randomized screening study.
METHODS: 27,700 inhabitants of Göteborg born between 1918 and 1922 (60-64 years old) who were randomly allocated to a control or a test group in 1982 were followed up. All people in the latter group were offered six fecal occult blood tests and rescreening 16 to 22 months later.
RESULTS: One hundred one carcinomas were diagnosed in the screened group and 128 in the control group during the seven years of follow-up. The number of carcinomas in the test group was half that in the control group during the first two years of follow-up, but equal during the rest of the follow-up period. The distribution of carcinomas according to Dukes classification was significantly better among the participants compared with the refusers (P < 0.02) but there was no difference in the Dukes distribution when the test and control groups as a whole were compared. The number of adenomas in the two groups during seven years of follow-up was the same.
CONCLUSION: The results indicate that screening and rescreening of a population has little influence upon the stage of the carcinomas in the test group compared with a control group during the first seven years of follow-up. The number of carcinomas was higher in the control than in the test group during the follow-up, probably because of a lead time effect during the screening.

Entities:  

Mesh:

Year:  1994        PMID: 8306829     DOI: 10.1007/BF02047531

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  5 in total

1.  Perception versus reality: overcoming barriers to colorectal cancer screening.

Authors:  Heather Bryant; S Elizabeth McGregor
Journal:  Can Fam Physician       Date:  2008-04       Impact factor: 3.275

2.  Pan-Canadian initiatives in colorectal cancer screening: adopting knowledge translation tools to accelerate uptake and impact.

Authors:  H E Bryant; S V Fekete; D H Major
Journal:  Curr Oncol       Date:  2011-06       Impact factor: 3.677

3.  Clinical features of colorectal cancer detected by the national cancer screening program.

Authors:  Dae-Do Park; Rumi Shin; Ji-Sun Kim; Heung-Kwon Oh; Seung-Yong Jeong; Kyu Joo Park; Jae-Gahb Park
Journal:  J Korean Soc Coloproctol       Date:  2010-12-31

4.  Can DNA sampling from the rectal mucosa be a novel tool for the detection of colorectal cancer?

Authors:  Ulrik Wallin; Ulf Gunnarsson; Bengt Glimelius; Alexandre Loktionov; Lars Påhlman
Journal:  Int J Colorectal Dis       Date:  2010-06-19       Impact factor: 2.571

Review 5.  Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities.

Authors:  C Knorr; B Reingruber; T Meyer; W Hohenberger; C Stremmel
Journal:  Int J Colorectal Dis       Date:  2003-08-29       Impact factor: 2.571

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.